Abstract：Objective: To explore relationship between serum TNF-α, IL-6, sIL-2R levels and the severity and prognosis of children with adenoid hypertrophy. Methods: The related data of 100 children with adenoid hypertrophy who were admitted to the hospital between August 2016 and August 2018 were retrospectively analyzed. The severity of hypertrophy and rate of adenoid re-hyperplasia were analyzed. The levels of serum indexes were compared among children with different severities of hypertrophy and different prognosis. The correlation between the three serum indexes and hypertrophy, and their predictive value for adenoid re-hyperplasia were analyzed. Results: Of the 100 children, there were 36, 32 and 32 cases with grade I, grade II and grade III hypertrophy, respectively. The rate of adenoid re-hyperplasia was 15.00% (15/100). Among them, there respectively were 2 cases (2.00%), 6 cases (6.00%), and 7 cases (7.00%) with adenoid re-hyperplasia (χ2 = 4.063, P>0.05). The order of levels of TNF-α, IL-6 and sIL-2R in children with different severities of hypertrophy from low to high was as follows: grade I, grade II and grade III (P<0.05). TNF-α, IL-6 and sIL-2R were positively correlated with the severity of adenoid hypertrophy (P<0.05). During follow-up, levels of TNF-α, IL-6 and sIL-2R in children with hyperplasia were significantly higher than those without (P<0.05). ROC curve analysis showed that the AUC of combined diagnosis (0.896) was better than that of single diagnosis with TNF-α, IL-6 or sIL-2R (0.845, 0.814, 0.709). Conclusion: The levels of serum TNF-α, IL-6 and sIL-2R are closely related to the severity of adenoid hypertrophy in children. All of them can be applied to predict the prognosis of children but the combined prediction of the three is better.
徐亚雄, 王远明, 杨刚, 李楚凌. 腺样体肥大儿童血清TNF-α IL-6 sIL-2R水平与肥大程度及预后的关系[J]. 河北医学, 2020, 26(3): 358-361.
XU Yaxiong, WANG Yuanming, YANG Gang, et al. Relationship between Serum TNF-α IL-6 sIL-2R Levels and the Severity and Prognosis of Children with Adenoid Hypertrophy. HeBei Med, 2020, 26(3): 358-361.
[1] Buzatto G P,Tamashiro E,Proencamodena J L,et al.The pathogens profile in children with otitis media with effusion and adenoid hypertrophy[J].Plos One,2017,12(2):1~12. [2] Szke H,Marodi M,Sallay Z,et al.Integrative versus conventional therapy of chronic otitis media with effusion and adenoid hypertrophy in children:a prospective observational study.[J].Forsch Komplementarmed,2016,23(4):231~239. [3] Cedeo E E G,Ortiz-Princz D,Figueredo S A C,et al.Adenoid hypertrophy and chronic rhinosinusitis:Helicobacter pylori on antral lavages,adenoid tissue and salival inmunoglobuline a on paediatric patients[J].Int Pediatr Otorhinolaryngol,2016,80(1):82~87. [4] Dixit Y,Tripathi P S.Community level evaluation of adenoid hypertrophy on the basis of symptom scoring and its X-ray correlation[J].Family Med Prim Care,2016,5(4):789~791. [5] 陆军,佘新泽,孙敬武.内镜下腺样体分度在儿童腺样体肥大诊治中的应用[J].中国耳鼻咽喉头颈外科,2011,18(1):39~40. [6] Gao Y Y,Wang H J,Wu Y.Superficial punctate keratopathy in a pediatric patient was related to adenoid hypertrophy and obstructive sleep apnea syndrome:a case report[J].Bmc Ophthalmol,2018,18(1):55~57. [7] Cakabay T,stun S B,Bayramoglu S E,et al.Evaluation of choroidal thickness in children with adenoid hypertrophy[J].Eur Arch Otorhinolaryngol,2018,275(2):439~442. [8] Daar G,Sar K,Gencer Z K,et al.The relation between childhood obesity and adenotonsillar hypertrophy[J].Eur Arch Otorhinolaryngol,2016,273(2):505~509. [9] Babademez M A,zda T,zda S.The common genetic variants of toll-like receptor and susceptibilityto adenoid hypertrophy:a hospital-based cohort study.[J].Turk Sci,2016,46(5):1449~1458. [10] Ant A,Kemaloglu Y K,Yilmaz M,et al.Craniofacial Deviations in the Children With Nasal Obstruction[J].Craniofac Surg,2017,28(3):625~628.
2020, Vol. 26 
冀公网安备13080202000677号